clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Protein Degradation Method Paves a Way for New Cancer Therapies
Informatics
AI Can Pick up Infant Neurological Problems from Intensive Care Video
News & Features
NCCN’s Cancer Care Guidelines Expanded to Include More Hereditary Risks
News & Features
Study Challenges Long-Standing Understanding of BRCA1 Mutations and Breast Cancer Risk
Molecular Dx
Kidney Disease and Diabetes Increase Cardiovascular Disease Risk
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Burn Rubber: Superluminal Medicines Gets $120M to Take GPCR Drugs to Clinic
Membrane proteins
Informatics
Burn Rubber: Superluminal Medicines Gets $120M to Take GPCR Drugs to Clinic
Jonathan D. Grinstein, PhD
September 11, 2024
0
Molecular Dx
Scientists Discover Cancer Protein Enhancing Anti-Tumoral Immune Response
September 15, 2023
0
News & Features
Mechanism Revealed of How Gamma Delta T Cells Recognize Cancer
September 6, 2023
0
News & Features
Novo Nordisk Acquires Obesity Drug Developer Inversago for up to $1.075B
August 11, 2023
0
News & Features
New Target for Addiction-Free Pain Treatment Found
May 3, 2023
0
Molecular Dx
Liquid Biopsy: How to Embrace Perfection?
June 15, 2022
0
News & Features
Gene Responsible for Group of Rare Immune Diseases Potentially Identified
February 28, 2020
0
Molecular Dx
Biocept to Study Clinical Utility, Cost Effectiveness of Assays in NSCLC Patients
August 6, 2018
0
Related Content
Personalized Medicine: Past, Present, and Future
Radiopharma Startup Alpha-9 Nets $175M Series C
Owkin and AstraZeneca Partner on AI-Powered gBRCA Screening for Breast Cancer
Novo Nordisk and Korro Bio Take RNA Editing to Cardiometabolic Diseases
Inside Precision Medicine